524
Views
9
CrossRef citations to date
0
Altmetric
Review

Improving the targeting of therapeutics with single-domain antibodies

, , &
Pages 561-570 | Received 23 Jul 2015, Accepted 15 Dec 2015, Published online: 25 Jan 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yongzhong Wang, Zhen Fan, Lei Shao, Xiaowei Kong, Xianjuan Hou, Dongrui Tian, Ying Sun, Yazhong Xiao & Li Yu. (2016) Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications. International Journal of Nanomedicine 11, pages 3287-3303.
Read now
Charles Oo & Suraj S. Kalbag. (2016) Leveraging the attributes of biologics and small molecules, and releasing the bottlenecks: a new wave of revolution in drug development. Expert Review of Clinical Pharmacology 9:6, pages 747-749.
Read now

Articles from other publishers (7)

Xi Xi, Weihan Sun, Hongrui Li, Qingjie Fan, Xitian Zhang & Fei Sun. (2021) A comparative study and evaluation of anti-EGFR nanobodies expressed in Pichia pastoris and Escherichia coli as antitumor moieties. Protein Expression and Purification 184, pages 105888.
Crossref
Sofia Tabares‐da Rosa, Linda A. Wogulis, Mark D. Wogulis, Gualberto González‐Sapienza & David K. Wilson. (2018) Structure and specificity of several triclocarban‐binding single domain camelid antibody fragments. Journal of Molecular Recognition 32:1.
Crossref
Scott A. Walper, Guillermo Lasarte Aragonés, Kim E. Sapsford, Carl W. BrownIIIIII, Clare E. Rowland, Joyce C. Breger & Igor L. Medintz. (2018) Detecting Biothreat Agents: From Current Diagnostics to Developing Sensor Technologies. ACS Sensors 3:10, pages 1894-2024.
Crossref
María Elena Iezzi, Lucía Policastro, Santiago Werbajh, Osvaldo Podhajcer & Gabriela Alicia Canziani. (2018) Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment. Frontiers in Immunology 9.
Crossref
Traian Sulea, Greg Hussack, Shannon Ryan, Jamshid Tanha & Enrico O. Purisima. (2018) Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) improves efficacy of a Clostridium difficile toxin A single-domain antibody. Scientific Reports 8:1.
Crossref
Gualberto Gonzalez-Sapienza, Martín A. Rossotti & Sofía Tabares-da Rosa. (2017) Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications. Frontiers in Immunology 8.
Crossref
Roshank Ahani, Farzin Roohvand, Reza Ahangari Cohan, Mohammad Hossein Etemadzadeh, Nasir Mohajel, Mahdi Behdani, Zahra Shahosseini, Navid Madani & Kayhan Azadmanesh. (2016) Sindbis Virus-Pseudotyped Lentiviral Vectors Carrying VEGFR2-Specific Nanobody for Potential Transductional Targeting of Tumor Vasculature. Molecular Biotechnology 58:11, pages 738-747.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.